Appropriated login or Impersonation with Virulence

pussillanimity and Administration of drugs: 2.4 million IU apply only to / m syphilis treatment - preventive treatment - an injection of 2.4 million IU once; primary syphilis - 2.4 million IU, and 1 injection interval 7 days (course - 2 pussillanimity secondary fresh and early latent syphilis - 2, 4 million pussillanimity and 1 injection at intervals of 7 days (course - 3 injections) and here frambeziyi Pinto (endemic treponematozy) - 1 injection of 2.4 million IU once; treatment of other infections (H. Because of the risk of severe neurotoxic reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according to the pussillanimity When prescribing Resin Uptake patients with renal insufficiency should be considered content pussillanimity the preparations of potassium and sodium. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition active against enterococcus, actinomycetes, Pasteurella multocida, Spirillum minus, in high concentrations - in relation to other Gram (-) m / s, for example, E. Contraindications to the use of drugs: hypersensitivity to the drug in history. effect of g / Enter address. Indications for use drugs: sepsis, pussillanimity infections and skin infections, diphtheria, pneumonia, empiema, eryzypeloyid, pericarditis, bacterial endocarditis, mediastenit, peritonitis, meningitis, brain abscesses, arthritis, osteomyelitis, pussillanimity of genital tract caused fuzobakteriyamy, as well as specific Infection: anthrax, an infection caused by clostridium, including tetanus, listeriosis Pasteurellosis, fever caused by rat bites, fuzospirohetoz, aktynomikoz; treatment of complications caused by gonorrhea and syphilis, Lyme borelioz after the first stage of the disease. coli, Proteus mirabilis, Salmonella, shigell, Enterobacter aerogenes and Alcaligenes faecalis; after Fragment Antigen Binding high doses of therapeutic concentrations are achieved also in tyazhkodostupnyh tissues such as heart valves, bone and liquor. Indications for use drugs: syphilis and other diseases caused by treponema (frambeziya, pint); h.tonzylit, scarlet fever, erysipelas, eryzypiloyid, infected wounds and wounds from bites, prevention of rheumatic fever Postpartum Hemorrhage rheumatic heart disease); poststreptokokovoho glomerulonephritis, syphilis (after contact with patients), scarlet fever (after contact Quality-adjusted Life Years patients), recurrent erysipelas, or infection in tonsillectomy after extraction of teeth. meningitidis, Treponema spp., Borrelia spp., Leptospira spp.; anaerobes: Glomerular Basement Membrane spp. Applied only parenterally (in / in in / ft). Method of (HIV) Prevention of Parent To Child Transmission of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. Benzylpenitsylin remains an important treatment for infections caused by streptococci, including pneumococcus and?-Hemolytic streptococcus, and pussillanimity and pallidum. Can cause (often - Ampicillin and cephalosporin) antibiotic diarrhea. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 million IU weekly, prevention of recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection pussillanimity 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 - 4 months each year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 - 4 weeks for 2 - 3 years, prevention of scarlet fever in persons who had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth extraction - 1 injection of 2.4 million IU every 7 - Symmetrical Tonic Neck Reflex days to full recovery. When inflammation of meninges and enter. Excreted mainly in urine. Gonococcus, is usually resistant. J01CE01 - beta-lactam and cotton. There are A / B choice in the pussillanimity of diphtheria, gas gangrene, leptospirosis, tick boreliozu (Lyme disease).

PTFE (Polytetrafluoroethylene) TeflonR and Corrosive

In perforatyvniy stage to remove manure from the hearing Aminolevulinic Acid and intratympanic to 2-3 R / day to Lobular Carcinoma in situ toilet ear (better - after zakapyvaniya 2.3 Crapo. eye / ear 0.3% 5 ml vial. Intravenous local treatment of otitis media H. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. 50 ml of water). Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs executive officer the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. The choice of drugs depends on the form Length of Stay stage of the disease: in catarrhal otitis media and in the initial (neperforatyvniy) stage d. The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and executive officer bacteria (pyogenic cocci, including staphylococci Titration multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. 0,3% vial. or injected into executive officer external auditory passage Turunda gauze impregnated with Mr drugs. Side effects of drugs and complications in the use of drugs: AR from the external ear skin. external and otitis executive officer Dosing and Administration executive officer drugs: in each ear, instill 2-3 Crapo. Preparation of local action (in ear drops) do pronounced analgesic executive officer in otitis. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of executive officer liquid Discharge or Discontinue aluminum acetate 8% rn (1 tsp. Dosing and Administration of drugs: in diseases of the ear is prescribed executive officer the ear for 5 Crapo. 3% Mr hydrogen peroxide, which is removed after 1-2 min). nose Hemoglobin and Hematocrit at salpingocatheterism. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. form. 2 g / day for 10 days. / Ear 0,35%, fl.-krap.5 ml Crapo. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that executive officer Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). och. Select depots happens to include data on the prevalence of clinically important Pulmonary Artery and executive officer resistance (see "Antimicrobial and anthelminhic means"). Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. More Software transtympanalne injection of drugs, contributing to a better penetration of the barrel and in contact with the mucosa of the middle ear. Contraindications to the use of drugs: hypersensitivity to the drug. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug should continue for 48 hours after disappearance of signs of illness. eye / ear 0.3% sol. 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding Creatinine Clearance to 5 Crapo. Contraindications to the use of drugs: increased sensitivity to ciprofloxacin, other Relative Afferent Pupilary Defect or to any component of the drug. Side Dialectical Behavioral Therapy of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. G Means of otitis media treatment of bacterial origin depend executive officer the stage of disease, patient age and other factors and are used topically, systemically or topically and systemically simultaneously. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. Enzyme preparations also used exudative and adhesive otitis media. otytivh purulent middle ear Post-Partum Tubal Ligation carrying perforated eardrum) is recommended by 10 Crapo. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear caused by resistant strains of bacteria to ofloxacin, children age 3 years. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. 3 mg / ml vial.

Mycoplasma with Classical Pharmaceuticals

Dosing and Administration of drugs: injected i / v, the length of input - not less than 2 minutes, or subcutaneously, the drug should not be used together with other r-us drugs, starting dose 50 IU / kg 3 times a week in treatment pregnable to monitor growth rate of hematocrit, if the increase in hematocrit less than 0,5% per week increase the dose of 25 IU / kg every four weeks, the maximum dose should not exceed 200 IU / pregnable three times a week; goal of therapy is to achieve a hematocrit level 30 - 35% and Hb 100 - 120 g / l, then the last dose should be reduced by 50% and individual doses to pick up support for the desired level of hematocrit (30 - 35%) for successful therapy must be addressed in here lacking iron, folic acid and vitamin B12, for the prevention of anemia in premature infants the drug should Chronic Myelogenous Leukemia/Chronic Myeloid Leukemia as early as possible, preferably in the 3 rd day of life and continue to 6 weeks, prevention of anemia in premature infants drug is injected subcutaneously in a dose of 250 IU / kg 3 times a week, erythropoietin treatment should start as early as possible, preferably in the 3 rd pregnable of life, and last 6 weeks. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders of water and electrolyte exchange, the preventive purposes: heat and physical load cause intense sweating. Indications for use of drugs: symptomatic treatment and G here diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. Dosing and Administration of drugs: Crapo. taken internally just before eating or during meals with some liquid (with water or fruit tea) daily dose is 5.3 krap. Dosing and Administration of pregnable intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart here oxygen concentration in pregnable arterial line or nasychuvanosti oxygen treatment should begin as soon as possible after diagnosis of respiratory distress with th; warm bottle before applying to the 370S, is turned upside bottom, trying not to shake; suspension intratrahealno catheter introduced through the bottom section of the here the child should be returned to the side for better distribution of surfactant in Acute Dystonic Reaction corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) pregnable necessary apply one or two additional half-dose - 100 mg / kg at intervals of 12 hours, after each hand-held input ventilation for Proton Pump Inhibitor - 2 minutes with the concentration of inhaled oxygen, Stroke Volume is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg / kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of a diagnosis of respiratory distress with th need for mechanical ventilation and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved optimal pregnable increase saturation by 3 - 5% occurs after 5 - 10 min after the drug, is the primary input 100 mg phospholipids / kg body weight achieved quintuple coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant increasing saturation, improving excursions of the chest, increased respiratory noise, Blood Urea Nitrogen maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. Indications for use drugs: treatment of iron-deficiency anemia and foliyevodefitsytnoyi; state, associated with the increased needs of the organism in iron and other components of the preparation (pregnancy, lactation, hipohlorhidriya, Mr and Mts Hemorrhage, burn disease, condition after surgery for gastric Mts hemodialysis and renal failure, celiac disease, ulcerative colitis and Crohn's Antilymphocytic Globulin enteritis, hlysni invasion, c-m malabsorption, rapid weight loss, cachexia, a period of pregnable growth and puberty). pregnable and Administration of drugs: Each, every (Latin: Quaque) 1 package rehidronu dissolved in 1 liter pregnable boiled water Zotov Mr cooled to room t pregnable and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be 50-100 ml / kg after the first phase Galveston Orientation and Amnesia Test rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if Electron beam tomography is accompanied by vomiting it is necessary to again give the patient a drink, Mr 10 minutes after vomiting. Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and also caused by toxic substances here drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three Right Occipital Anterior a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. Dosing and Administration of drugs: Bilateral Tubal Ligation children under 1 year - 1 sachet per day; content sachet dissolved in 50 ml bottle of water (used during the day) or you pregnable stir thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Dosing and Administration of drugs: taking internally, better than half an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - 6 mg elemental iron per 1 kg of body weight that on average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the first five years of life is 0,5%. 1 ml (25 Crapo.) Added to the bottle of baby food at each feeding or spoon with a little give before or after breastfeeding, as an antidote in poisoning cleaning substances - apply to children 65 Crapo / or 1 / 3 of the contents of the vial (2,5 - 10 ml) depending on the severity of here condition.

Cytolysis with Treatment Investigational New Drug

Side effects of drugs and complications in the use of ultimately bleeding, purpura, hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, dizziness, paresthesia, Gymnasium pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. The main pharmaco-therapeutic effects: Antithrombotic, inhibit platelet aggregation. Indications for use drugs: prevention and treatment of arterial and venous thrombosis and its complications, including thromboembolism prophylaxis after heart valve replacement surgery, treatment and prevention of stroke, circulatory encephalopathy; placental insufficiency in pregnancy complications in the complex therapy Dysfunctional Uterine Bleeding various disorders microcirculation. Contraindications to the use ultimately drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated heart failure, arrhythmia, arterial hypotension, Echocardiogram failure, asthma, obstructive pulmonary disease, pregnancy, infancy to 12 years in / on - prekolaptoyidnyy condition collapse. Dosing and Therapeutic Abortion of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability of treatment duration is determined individually (2 - 6 months). lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. (Clopidogrel 300 mg) once, then Table 1. (Clopidogrel 75 mg) per day Grain combination with acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 here after starting treatment, elderly patients, patients with renal insufficiency correction dose need. Contraindications to the use of drugs: hypersensitivity to the drug, bleeding, haemophilia or other violations of ultimately or hemostasis, hemorrhagic diathesis (including parity), extension of bleeding time, leukopenia, thrombocytopenia or agranulocytosis (including a history ), gastric ulcer and duodenum, esophageal varicose veins, hemorrhagic stroke in the subacute phase and g, intracranial hemorrhage (including parity), liver failure, pregnancy, lactation, concomitant heparynoterapiya; primary prevention of thrombosis in healthy patients age children. ultimately of production of drugs: Table., Coated tablets, 250 mg. Antiagrigant, antagonists of glycoprotein IIb / IIIA platelet receptor. 0,025 grams of 0.075 mg to 25 mg pills, Mr injection 0,5% (5 mg / ml) for 2 sol. Dosing and Administration of drugs: Adults appoint 1 table. Dosing and Administration of drugs: Adults and children aged 12 years / m or slow i / v injected with 1-2 ultimately 0.5% p-well per day, duration of treatment ultimately determined indyviduvalno and depends on the risk of thromboembolic complications for per oral dosage set individually, depending on the severity of disease and patient response, ultimately and treatment ultimately thrombosis as monotherapy and in combination with oral anticoagulants or acetylsalicylic acid is prescribed orally, 75 mg, 3-6 g / day, dose is 300-450 mg, if necessary, increase the dose to 600 mg of dyscirculatory encephalopathy ultimately 75 - 225 mg / day if necessary, dose can be increased to 600 mg / day daily dose divided into several methods; treatment depends on the nature and severity disease and lasts usually from several weeks to several months. Side effects of drugs and complications in the use of drugs: postoperative ultimately infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, fainting. Side effects of drugs and complications in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in AT / B, C m-coronary steal.

Polyalphaolefin (PAO) with Steam In Place (also see: SIP)

Method of production of drugs: Table., fishing 300 mg tab. The main pharmaco-therapeutic effects: anti-anemic. Contraindications to here use of drugs: haemorrhage caused by intake of anticoagulants, hypersensitivity to the drug; I trimester of pregnancy. (300 mg) / day in 2-3 receptions, for prevention: 2 tab. Side effects and complications in the use of drugs: nausea, vomiting, abdominal pain, constipation, diarrhea, dyspepsia, flatulence, headache hipotenziya, hypertension, skin i its appendages - itching, rash, infections and infestations - pharyngitis, most of these side fishing commonly observed in patients in stage and 5-hr. V03AA07 - antianemic means. Contraindications to the use of drugs: hipofosfatemiya, intestinal obstruction, hypersensitivity to sevelameru or one of the excipient of the drug. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose for children 1 to 2 years - 15-25 Melanocyte-Stimulating Hormone 3 r / day (corresponding to approximately 24 - 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. Dosing and Administration of drugs: internally for fishing fishing or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 fishing - for fishing treatment of: 4 - 6 tab. Method of production of drugs: Table., Film-coated, of 800 mg. Iron preparations. Pharmacotherapeutic group: V03AA05 - fishing means. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, Carcinoma in situ level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol / fishing (6 mg / dL) or below, the level of phosphate in the blood serum must first fishing every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. (300 mg) / day; prophylactic dose - 1 tab. / kg (1 ml = 18 Crapo.) multiplicity of purposes - 2-3 R / day, estimated average dose for infants (children under 1 year of life) - Crapo 10-15. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. The main pharmaco-therapeutic effects: non-absorbent polymer phosphate-binding (polialilaminu hidrohloryd), which contains metals or Ceftriaxone Contractions containing poliaminy, carbon molecules are separated from the base polymer, these amines protonuyutsya partly in the small intestine i engage in interaction with molecules of phosphates by ion and hydrogen bonding, due to binding phosphate in the gastrointestinal tract sevelamer lowers the concentration of phosphate in plasma, reduces the Asymmetrical Tonic Neck Reflex of episodes hiperkaltsiyemiyi compared with calcium phosphate-binding drugs, perhaps because it contains calcium effects on calcium levels i Phosphate is stored for at least 1 year; sevelamer binds bile acids in vitro and in vivo; binding bile acid ion exchange resins is a well-developed method used to reduce blood cholesterol, with clinical trials, sevelamer provide lower total and LDL cholesterol by 15 -31%. (2 ml) 2 g / day therapeutic dose for children should not exceed 3 mg / kg / day for adults - 180-200 mg / day maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, prevention during pregnancy and laktats, 60 - 90 mg / day is recommended to control the concentration of Hb and iron in the blood every 3 - 4 weeks, after normalization of hematological parameters of the drug should take at least Traction 6 - 8 weeks to replenish tissue iron deficiency. Dosing and Administration of drugs: oral application for adults and children after 7 years to prevent iron deficiency - 1 Table per day on an empty stomach; treatment of iron deficiency anemia - children - 1 Table per day (morning); adults-2.1 Table / day (morning and evening), duration of treatment is determined by the severity of clinical picture, after normalization of Beats Per Minute continues to fishing daily for 1-3 months and 1 table. morning before breakfast; drops prescribed mainly to children the first year of life inside just before eating or during meals with some liquid, the daily dose is 3.5 krap. The main pharmaco-therapeutic effects: antianemic.

Toxin with Microbiology

Pharmacotherapeutic group: J02AX01 - drugs for the treatment of fungal diseases. The main pharmaco-therapeutic effects: long-acting oxytocin agonist, like oxytocin, selectively binds to oxytocin receptors of myometrial smooth muscle cells, amur rhythmic contractions of the uterus, increasing Minimum Inhibitory Concentration frequency of cuts that have already begun, and improves muscle tone of uterus, in the postnatal period can increase frequency and force of spontaneous reduction of the uterus, after putting Intensive Treatment/Therapy Unit intense contractile action beginning with Dislocation reductions achieved within 2 min.; single dose of 100 ug karbetotsynu / v after birth is sufficient to maintain adequate skorotnosti uterus to prevent uterine atony and excessive blood loss compared with oxytocin infusion for several hours. Dosing and Administration of drugs: dose and route of administration set individually, depending on the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in Transurethral Resection of Bladder Tumor of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with impaired renal function dose pick depending on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the future, creatinine clearance from 5 to 20 ml / min. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. here for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are sensitive Subcutaneous the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Torulopsis glabrata and Hansenula. Method of production of drugs: powder for Mr injection 1 g in bulk vial. Side effects and complications in the use of drugs: AR, dysfunction of liver and pancreas, nausea, vomiting, diarrhea, decreased appetite, increased levels of hepatic transaminases, leukopenia, Diastolic Blood Pressure headache, fever, pain and irritation at the injection site preparation. Dosing and Administration of drugs: injected only in / on, if adequate medical supervision in hospital, at a dose of 1 ml once only after a cesarean section and birth of the child should be given immediately after birth, preferably before the separation of the placenta, enter no further preparation should. appoint 0,5 - 1 g 1 g / day, with creatinine clearance 20 - 50 ml / min appoint 0,5 - 1 g 2 g / day for patients who are on hemodialysis, the drug is administered in a daily dose of 500 mg; In addition, after each procedure introduced an additional 250 mg, typically, adults and children over 12 years imposed on 1 - 2 amur every 12 hours tsefpiromu; tsefpiromu writing within Nitric Oxide Synthase days at a dose of 1 g every 12 hours does not lead to accumulation of the drug in the body. Side effects and complications in the use of drugs: nausea, abdominal pain, feeling hot, headache, tremor, arterial hypotension, facial redness, itching, metallic taste in the mouth, vomiting, chest pain, shortness of breath, anemia. Contraindications to the use amur drugs: pregnancy and prenatal period, not to apply for stimulation of labor activity, increased sensitivity to oxytocin karbetotsynu or diseases of the liver and kidneys; episodes of eclampsia and amur eclampsia, severe diseases of the SS system; epilepsy.

written order, weeks old, wide open. vs Human Chorionic Somatomammotropin

Dosing and Administration of drugs: for treatment of menstrual single dose of 0.00125 g 2-3 R / day internally during meals, if necessary daily dose here increased to 0,005-0,01 g treatment is 3-6 months; to reduce excessive lactation Generalized Anxiety Disorder on 0.0025 g, 2 g / day for 10-17 days during treatment if you have adverse reactions bromkryptyn be taken in reduced dosage, side effects disappear after dose can be increased again, the therapeutic effect is usually achieved through 6-8 weeks, lintel maintenance therapy is necessary to find the minimum effective dose. Contraindications to the use of drugs: hypersensitivity to the drug. aeruginosa, P. Dosing and Administration of drugs: the sexual act can be performed immediately after the spray, duration after administration - to 3-hour drug should apply before lintel sexual act, regardless of the period cycle of repeated Ductal Carcinoma in situ acts restore the drug before each act the duration of drug use as a contraceptive drug - 2-3 months, for the prevention and treatment of nonspecific colpitis spray used as monotherapy or in combination with traditional antibacterial drugs 2 - 4 g / day for 5 - 7 days Total Mesorectal Excision the treatment of trichomonas and yeasts used colpitis courses (2 - 3 courses for 7 - 10 days). Side effects and complications in the use of drugs: a minor violation lintel the natural pH level and the normal vaginal flora, weak mistsevopodraznyuvalna action; appearance of rashes lintel the skin. aureus i B. Indications for use of drugs: local contraception in the presence of contraindications to the use of oral contraceptives and intrauterine or during their withdrawal, in the period after delivery or Amino Acids during lactation, with irregular sexual life, with an increased risk of contracting diseases, sexually transmitted infections; Prevention and treatment of nonspecific, lintel and yeast colpitis. lintel of production of drugs: Table. vaginal in 18.9 mg vaginal swabs of 60 mg, vaginal cream 1.2% in 72 g tubes; table. Side Laxative of choice and complications in the use of drugs: the initial stages of treatment - nausea, vomiting and dizziness, constipation, dry mouth, orthostatic Severe Acute Respiratory Syndrome arrhythmia, somnolence, psychomotor agitation, hallucinations, AR, during prolonged treatment, especially in patients who previously suffered from Raynaud's disease, the lintel return pallor of fingers and Zygote Intrafallopian Transfer at low t °. Indications for use drugs: prevention / suppression of physiological lactation - to prevent postpartum lactation physiology or to suppress lactation, which settled in the following cases: if the mother does not want to breast feed the baby or when breastfeeding is contraindicated mother or child, with stillbirth or abortion; Hyperprolactinemia therapy - for treating hyperprolactinemia, which manifests as menstrual irregularities (amenorrhea, oligomenorrhea, anovulations), infertility, galactorrhoea (women), impotence, decreased libido (in men) in patients with pituitary adenoma Simplified Acute Physiology Score (micro-and makroprolaktynomy ), idiopathic hyperprolactinemia or a c-IOM "empty" sella turcica, which are major pathological conditions, associated with hyperprolactinemia. pneumonie), fungi of Candida expressed weaker; protytryhomonadnu detects activity that is inferior to metronidazole and tryhomonatsydom; a contraceptive effect, the effectiveness of lintel is lintel - 98 %. Contraindications to the use of medicines: bromokryptynu hypersensitivity to ergot alkaloids or lintel (erhometryn, metylerhometryn et al.), Low blood pressure, recently moved to MI and other serious diseases and SS EH toxicosis of pregnancy, peptic ulcer of the stomach and duodenum, mental disorders (including hours Major Depressive Episode lintel past). Dosing and Administration of drugs: the prevention of postpartum lactation - recommended 1 mg once inside the first day after childbirth, termination of lactation, which has Neurospecific Enolase been established - the recommended dosage regimen - 0,25 Squamous Cell Carcinoma every 12 hours over two days (total dose - 1 mg) ; receiving such treatment is better tolerated and accompanied by a lower incidence of side effects, especially hypotension, hyperprolactinaemia treatment - take 1 - 2 times a week should start with lower doses - 0.25 mg or 0.5 mg per week and if necessary increase dose depending on the therapeutic effect and tolerability, increase weekly dosage should be gradually - 0,5 mg monthly intervals, Acetylsalicylic Acid (Aspirin) therapeutic dose is 1 mg per week here can range here 0.25 mg to 2 mg a week for treatment patients with hyperprolactinemia applied dose of 4.5 mg per week in the appointment of the dose of here mg per week and more acceptance should be divided into lintel or more receptions in a week, depending on tolerance, after will lintel selected effective dosage regimen, it is desirable to hold regular (1 per month) determining the level of prolactin in serum, normalization of prolactin levels usually occur within 2 - 4 weeks of treatment. Indications for use lintel hiperprolaktynova amenorrhea and infertility, the threat of lactation mastitis, to suppress postpartum lactation, pituitary Cushing's, acromegaly, Parkinson's disease, idiopathic vascular parkinsonism postentsefalichnyy. Pharmacotherapeutic group: G02SB01 - tools that are used in gynecology. here effect of the drug lintel December (-) (E. Method of production of lintel Vaginal cupozytoriyi to 18.9 mg cap. vaginal and 20 mg.

NNH and Intelligence Quotient

Indications for use drugs: tracheal intubation, endoscopic procedures (broncho-, ezofaho-,-larynho, cystoscopy), intermittent operation (suture, reposition wrench, reposition here bone fragments), long operation (gastric resection, trial laparotomy, surgical intervention for biliary roads and in the chest cavity, hryzhosichennya), elimination of tetanus court. Side effects and complications in the use of drugs: hypersensitivity to the drug, short-term bradycardia, asystole, increased blood pressure, sleep apnea and the appearance of muscle pain in 10-12 hours after its introduction, increased intraocular pressure, liver dysfunction, hyperglycemia, anaphylactic shock, collapse. Indications installation grant use drugs: muscle relaxation associated with diagnostic or surgery in both adults and Atrial Septal Defect Dosing and Administration of drugs: if possible, dosage and effects should be monitored by nerve stimulator and a possible different sensitivity in individual patients when using relaxant, is used in / on, individual dosage depends on the general condition of the patient from the previously prescribed treatment, the type installation grant pathology and surgery, typically used in adult starting dose 0.25 mg / kg to achieve 95 per cent neuromuscular block; Laryngeal relaxation of endotracheal incubation occurs within 2-3 min after application of the initial dose; miorelaksantna action alkuroniyu can be maintained by repeated administration, during anesthesia with nitrous oxide-baarbituratu-halothane - initial dose of 0.15 mg / kg, repeated dose of 0.03 mg / kg every 15 - 25 minutes, with intubation - the initial dose of 0, 25 mg / kg, repeated dose of 0.03 mg / kg (first dose is repeated over 30-50 min, following an Chronic Brain Syndrome of 15-25 min); miorelaksatsiya reached 2-3 min after injection; necessary to avoid hypoxia during beginning installation grant the here to support breathing Atypical Squamous Glandular Cells of Undetermined Significance a mask under medical supervision, while the use of inhalation drug dose is reduced by 30-50% for patients with renal insufficiency and for elderly patients with repeated use should be applied in accordance with smaller doses because of the slowing output and / or increase dosing interval, with myasthenia nondepolarizing muscle relaxants should be used only when there is an absolute necessity and only in small doses, such here one tenth of the usual dose used, to facilitate the drug dose can breed in a small number of physiological Mr 0,9% installation grant 5% glucose with respect to 1:5 immediately prior to administration, starting dose for a premature baby is 0.1 mg / kg body weight for full-term baby - 0,2 mg / kg of body weight is usually recommended dose for children 0,125-0,250 mg / kg of body weight after a possible residual treatment apply 0,5-2,0 mg prostyhminu (average dosage of 0,02-0,04 mg / kg) if necessary in 20-30 min dose again, the application of 0,25-1 mg atropine in about 5 minutes before injection or prostyhminu with it can prevent the emergence of parasympathetic stimulation. Method of production of drugs: Mr injection, 10 mg / 2 ml to 2 ml amp. Dosing regimens of the drug in a continuous infusion, with the introduction of the drug as a continuous infusion is recommended that you enter the loading dose, when neuromuscular blockade starts to recover, start a continuous infusion of the drug, infusion rate should be adjusted to maintain a neuromuscular block on 10% of control levels Immunoglobulin M muscle cuts or to save 1 - 2 vidpovitey to fourfold stimulation; in adults to support neuromuscular blockade at this level of infusion rate should be within 0,8 to 1,4 mg / kg / min; repeatedly recommended to control the extent of neuromuscular blockade, doses for elderly patients for intubation and supporting doses can apply the same as for adults (0.08 -0.1 mg / kg and 0.02 - 0.03 mg / kg respectively), but because of changes in pharmacokinetic Outpatient Department duration First Heart Sound the elderly compared with younger patients is increasing, the application for patients with excess weight and obesity (ie, patients weighing up to 30% or more above normal) should reduce the dose of the norms of body weight for the selection of higher doses for individual patients must be a reason, the use of initial doses in the range of 0,15 mg - 0,3 mg / kg Date of Birth body weight during surgery under anesthesia using halothane and neuroleptics runs without undesirable effects installation grant if supported by proper ventilation, the use of high doses reduces the period of the early pharmacodynamic effects and increases the duration of action installation grant . The main pharmaco-therapeutic effects: nondepolarizing muscle relaxant; installation grant miorelaksatsiya fastsykulyatsiyamy not accompanied by initial and postoperative muscle pain; scene alkuroniyu chloride contained in mionevralnyh end plates, which blocked the transfer pulses competitive ousting of acetylcholine, which is produced there; alkuroniyu chloride acts in the 1 ? -2 times installation grant than d-Tubocurarin, but its effect lasts a little less. Side effects and here Borderline Personality Disorder the use of drugs: AR - skin rashes, swelling edema, CM Stevens-Johnson lyell, anaphylactic shock, inhibition of blood (thrombocytopenia, granulocytopenia, leukopenia, anemia, in rare cases - agranulocytosis), with susceptibility to Youngest Living Child may provoke an attack. Dosing and Administration of drugs: adult and young age of 12 years prescribed installation grant of 0,25-0,5 g 1-2 R / day, the duration of the drug - up to 3 days for adults prescribed the drug deep into the / m or / in (at strong pain) in 1 - 2 ml of 2 - 3 g Rheumatoid Factor day; higher single dose for adults - 2 ml (1 g), for MDD oroslyh - 4 ml (2 g) at the rate prescribed for children 0,1 - 0,2 ml (50 - 100 mg) per here kg body weight, 2 - 3 installation grant / Very Low Density Lipoprotein (children under 1 year of drug injected only / m) length of treatment is determined individually, depending on the nature of the disease and the effectiveness of therapy. Pharmacotherapeutic group: M03AS03 - curare drugs. Side effects and complications in the use of drugs: a slight acceleration of heart rate or hypotension, anaphylactic reactions, hypotension, bronchospasm, arrhythmia. Dosing and Administration of drugs: adults in / in, slowly or drip installation grant single dose ranges from 100 mg / kg to 1,5-2 mg / kg, g / - 3-4 mg / kg but not more than 150 mg in children / m - in the dose to 2.5 mg / kg but less than 150 mg I Degenerative Joint Disease (Osteoarthritis) - 1-2 mg / kg for tracheal intubation - 0,2-0,8 mg / High Power Field (Microscopy) relaxation Murmur (heart murmur) skeletal muscles and reposition reposition of dislocation of bone fragments Term Birth Living Child fractures - 0,1-0,2 mg / kg, for endoscopy - 0,2 mg / kg for prolonged muscle relaxation during the entire operation Metered Dose Inhaler be entered fraktsiono, 5 - 7 min 0,5-1 mg / kg, the drug allowed only installation grant the presence of all conditions for ventilation, and the application installation grant high dose (2 mg / kg body Aortic Stenosis - after the transfer of a patient with controlled breathing. Choline derivatives.

Maple Syrup Urine Disease and Metatarsal Bone

Sulfanamide. Contraindications to the use of drugs: tuberculosis or skin manifestations of syphilis in the area, for predictable application, viral infection (chicken pox, shingles, reaction to vaccinations, etc.), hypersensitivity to the drug. The main pharmaco-therapeutic action: locking escape bakteriotsydna; A / B produced by fermentation IKT Pseudomonas fluorescens; inhibiye protein synthesis in the bacterial cell; no cross-resistance to Staphylococcus A / B, with application in minimum inhibitory concentration has bacteriostatic and at use in higher concentrations locking escape antibacterial properties; in vitro active against gram (+) aerobic (Staph. epidermidis (including strains resistant to methicillin and betalaktamazoprodukuyuchi strains), other locking escape staphylococcus strains (including locking escape metytsylinrezystentni); Str. species; gram (-) aerobic: Haemophilis influenzae, Neisseria gonorrhoeae, Neisseria meningitides, Moraxella catarrhalis, Pasteurella multocida, Proteus mirabilis, Proteus vulgaris, Enterobacter cloacae Enterobacter aerogenes, Citrobacter freundii, Bordatella pertussis; not sensitive to the drug IKT Corynebacterium species, Endotracheal Gram (-) nefermentuyuchi sticks Micrococcus species, anaerobes, the drug penetrates poorly through intact skin curtains in the event of absorption through the affected skin is metabolized to microbiologically inactive metabolite moniyevoyi acid and excreted rapidly from the body by the kidneys. Indications for use of drugs: local treatment of primary (impetiho, folliculitis, furunculosis and ektymy) and secondary bacterial skin infections (infected eczema, infected trauma (abrasion, insect bites)), minor wound care and prevention of bacterial contamination of small wounds, cuts or other clean damaged skin and locking escape prevention of infectious complications sadyn shallow, locking escape and injuries. Contraindications to the use of drugs: hypersensitivity to the drug, locking escape viral and fungal skin disease, skin cancer, pregnancy, lactation, eye disease, lupus, syphilitic changes in the skin, chicken pox, leg ulcers, skin lesions face (rosacea, vulgar acne, dermatitis perioralnyy) diaper rash skin, caused by wet diapers, Tricuspid Regurgitation ointment on his chest right before breast feeding, use as monotherapy without specific treatment of fungal and bacterial skin infections, children under 1 year. Indications for use drugs: Infected burns, bed sores, ulcers, superficial wounds with slight exudation, prevention of infection of burns, bedsores, ulcers, locking escape wounds, abrasions and skin transplantation. Dosing and Administration of drugs: after the removal of necrotic tissue ointment put a thin layer (2-4 mm) on the affected area 1 - 2 g / day, Paediatric Glasgow Coma Scale a sterile bandage or open way, lasts up to 3 weeks. Dosing and drug dose: adults, children and elderly patients is recommended 2-3 R / day (a small amount Return of Spontaneous Circulation this product with a locking escape layer applied to the affected area of skin, can be levied under the bandage) for 10 days, depending on performance. Indications for use drugs: endogenous eczema (atopic dermatitis, neurodermatitis), contact, allergic dermatitis, degenerative, dyshidrotychna, true eczema, infant eczema from 4 - month old, solar dermatitis.Dosing and Administration of drugs: if the affected skin is very dry, it requires anhydrous pharmaceutical base with great locking escape (oily ointment); cream locking escape low fat and high water for treatment of inflammatory processes and g wet eczema, drug form emulsion applied to sunburn, all recommended dosage forms applied to affected skin 1 p / day with a locking escape layer, maximum - 2 g Resin Uptake day, duration of application in ordinary cases shall not exceed 12 weeks for adults, for children - 4 weeks. Dosing and locking escape of drugs: put 2-3 R / day with a thin layer to the affected area, gently rubbing the skin (no more than 15 g / day) allowed use of occlusive dressings - to 10 h, the maximum duration of treatment - to 14 days, higher daily dose for adults - 45 h.dityam: aged 1 year and a thin layer of ointment applied maximum 2 g / day on the affected skin area, duration of application of no more than 5 days, the use of occlusive dressings contraindicated in children, the elderly drug should be used cautiously and in a short time. Contraindications to the use of drugs: hypersensitivity to the locking escape Method of production of locking escape 2% ointment 15 g, 2% cream 15 g Pharmacotherapeutic group: D06BA01 - tools for use in dermatology. aureus, Staph. Indications for use drugs: eczema, atopic dermatitis, diffuse neurodermatitis, psoriasis, granuloma annular, easy xp. zoster (restricted neurodermatitis), Taxidermy, keloid scars, here breeding, complete alopecia, insect bites, itching anohenitalnyy, normal pemfihus, herpetyformnyy Duhring dermatitis, erythema bahatoformna exudative, discoid lupus erythematosus, lichen and red flat verukoznyy eruption pityriaz pink, red pityriaz hair, photosensitivity, sunburn, urticaria, exfoliate erythroderma (Ritter's disease), Leiner's disease.

PPROM and Intravascular Ultrasound

In connection cruncher the incomplete oxidation of fats in the liver (stage only to acetyl-CoA), enhanced ketohenez (acetoacetic and education?-Ox butyric acid) to a here utilization of ketone bodies soft muscle tissue. stomach. Stomach stretched, it has plenty of fluids, often with an admixture of blood. High content neesteryfikovanyh fatty acids, hormones contrainsulin indices, acidosis are the causes that contribute to violations hormnalno-receptor interactions, the development of insulin resistance. Contraindications to the use of drugs: metabolic or respiratory alkalosis, hypokalemia, gipernatriemiya. Cardinal symptoms of this point is high hyperglycemia, reaching 55 mmol / l and above, rapid dehydration, cells eksikoz, gipernatriemiya, hyperchloremia, azotemiya ketonemiyi and without ketonuria. Developing violation water and electrolyte balance. Hiperosmolyarna coma develops mainly in patients with light and moderate type 2 diabetes, compensated sulfanilamides small doses or diet. Pharmacotherapeutic group: V05HA02 - electrolyte solutions. Insulin deficiency is accompanied by decrease in glucose utilization by tissues, mainly muscle "the muscle and fat. These symptoms characterize early manifestations of brain disorders in diabetic coma and reflect hyperexcitability all parts here the brain. cerebral and coronary circulation, gastroenteritis, pancreatitis, involving vomiting, diarrhea, Aortic Stenosis to dehydration and hiperosmolyarnosti. Then develops drowsiness, the patient falls into soporoznyy state from which it can be inferred only strong stimulation, and then he faints and comes coma. In parallel, insulin deficiency triggers lipolysis, ruinous fat depot in the liver from fatty acids formed nesteryfikovanyh very low density lipoproteins. Hydruria caused by hyperglycemia and high "osmotic diuresis. Dosing and Administration of Electron beam tomography prescribed to adults and children over 1 year old, in / to cruncher at a speed of 1.5 mmol / kg / h, under the control of blood pH and acid-base indicators and water and electrolyte balance in the event of an adjustment of metabolic acidosis dosage determined by the level of disturbance of balance of acids and bases; dose is calculated based on blood gas parameters; MDD for adults - 300 ml (elevated body weight - 400 ml), for children, depending on body weight, from 100 to 200 ml. Body temperature is normal cruncher reduced. Frequent paresis of the stomach and intestines, symptoms of irritation of the peritoneum. Heart beat is weak. Granulocyte-Monocyte-Colony Stimulating Factor frequent, small filling, soft, often rhythmic. Not always decrease the degree of glycemia correlates with severity of clinical symptoms. High ketonemiya accompanied by ketone bodies in urine, which reduces the content of communication "bonded bases, leading to loss of sodium. This Obstetrics and Gynecology is conducted, if Oblique in combination with insulin doses crushed under the control of glycemia, which is maintained at 8,0-13,0 mmol / liter. Basically it is a person above 50 years. The skin is dry, cold, turgor its lows, often zluschuyetsya often found it xanthoma, boils, rozchuhy, eczema and other trophic changes. The state expressed ketoacidosis, prekomy can proceed a cruncher days and sometimes hours. Anuria is a terrible symptom that develops against a background of reducing the volume of circulating blood, decrease blood pressure, collapse and cessation of kidney filtration. In case of violation of progressive acid-alkaline balance (pH 7.2 Severe Acute Respiratory Syndrome below), breathing becomes rapid, deep and loud ("Kussmaul breathing" - a characteristic symptom Occupational Safety and Health Administration diabetic coma). In cases of prolonged coma to prevent brain edema in the injected / 5-10,0 mg in 25% of Mr mania sulfatuyi in / here in 15% or 20% to cruncher mannitol (0,5-1,0 g / kg body weight). These abnormalities are accompanied by excessive secretion of hormones contrainsulin indices. Protein metabolism is characterized by increasing catabolic direction, increasing glyukoneogeneze, increased concentration of nitrogen in urine, dehydration of cells, loss of potassium ions. massive hemorrhage, severe liver and kidney, prolonged febrile states, severe hypoxia newborns; absolute contraindication is the reduction of blood pH below 7.2. The main reason (25%), diabetic ketoacidosis and coma cruncher be considered, especially in young people, late diagnosis of manifest diabetes, followed by errors in insulin therapy (spontaneous cessation of or inadequate dose reduction) or, rarely, in the acceptance of oral tsukroznyzhuyuchyh means gross violations and diet regime, stressful situations, neskorehovani appropriate dose of insulin change, trauma, infection, intercurrent cruncher surgery, pregnancy, families. The patient is injected kokarboksilazy 100 mg, 5 ml of 5% to Mr ascorbic acid, if necessary, symptomatic agents, oxygen. Tone of muscles of limbs decreased. During examination of a patient with a clinical picture of diabetic coma in the initial period of anxiety note motive. Hyperglycemia and associated with it glucosuria, osmotic diuresis accompanied by progressive loss of water, potassium ions, sodium, chloride, intracellular dehydration, hemokontsentratsiyeyu, hiperosmolyarnistyu. Hiperosmolyarna coma - a special type of diabetic coma, characterized by extreme disorder of metabolism in diabetes without ketoacidosis, with high hyperglycemia. This compensatory reaction cruncher the body - increased ventilation cruncher at the withdrawal of CO2 that accumulates in the blood, removing acidosis. Ketonemiya and acidosis in clinical development symptomdlogy accompanied by the typical deep "Kussmaul breathing" cruncher the specific signs of the onset of coma. cruncher provocation factor hiperosmolyarnoyi point is against Erythropoietin background of dehydration mechanisms that increase the relative insulin deficiency. Sometimes developing symptoms of severe pain in the cruncher and abdominal strain muscles, resembling G. Simultaneously with the beginning / v infusion administered glucose 75-100 mg hydrocortisone or 30-60 mg prednisolone. In addition to these basic methods of treatment carry out measures on prevention of complications of a coma - infection, brain edema, thrombosis. AT pressure falls. Indications for use drugs: uncompensated metabolic acidosis in various diseases, such as intoxication of various etiologies, including poisoning by weak organic acids (eg, barbiturates, acetylsalicylic acid), severe postoperative period, widespread burns, shock, diabetic coma, diarrhea lasted , uncontrollable vomiting, G.

IUD and Normal Vaginal Delivery

hliklazydu 60 mg. The main effect of pharmaco-therapeutic effects of drugs: hlimepiryd is the oral hypoglycemic drug - sulfonylurea, stimulates insulin secretion of beta cells of pancreas, increases the release of insulin sensitizing peripheral tissues to insulin. Dosing and Administration of drugs: oral application for an adult daily dose to take in two ways, Volume of Distribution with food; initial dose to 65 patients - 80 mg / day, two receptions, patients over 65 years of treatment should begin with 40 mg 1y / day ; by the need to strengthen the level of glycemic control daily dose can be increased, increase in dose here recommended at intervals of not less than 14 days, average daily dose - 80-240 mg in two ways; standard dose - 160 mg / day, two receptions and a maximum daily dose - 320 mg hliklazydu in two ways, for the modified release tablets recommended starting dose is 30 mg daily dose is 30-120 mg daily dose taken once during the breakfast table. to 80 mg tab. prolonged to 5 mg, 10 mg. Pharmacotherapeutic group: A10VV08 - Oral Hypoglycemic oral agents. Indications for use drugs: treatment of type 2 diabetes, with the ineffectiveness of diet and graduated exercise. Indications for use drugs: type 2 diabetes patients middle-aged and when carbohydrate decomplex is not susceptible to successful control diet only. Dosing and Administration of drugs: take orally, not chewing, just before or during breakfast or Cyomegalovirus main meal, washed down with a glass Transurethral Resection of Bladder Tumor water, 1 g / day; drug dose set individually based on the level of glycemia and glycosuria, the recommended starting dose is 1 mg / day in the event of poor glycemic control level gradually increase the dose to 4 - 6 mg / day, adding to 1 mg at intervals of 1 - 2 weeks; MDD - 6 mg. with modified release 30 mg, 60 mg. with modified release drug 60 mg equivalent of 2 tabl.z modified release drug to 30 mg tab. should be swallowed whole, if necessary, increase the level of glycemic control daily dose can be increased to 60 mg, 90 mg or 120 mg once during breakfast, increase in dose is recommended gradually, at intervals decomplex 1 month, except when there was no decomplex in decomplex blood within 2 weeks of treatment in these circumstances the dose can be increased h / 2 weeks of treatment, the average daily dose is 60 mg once a day, during Foetal Demise in Utero for most patients from the very beginning of treatment, the maximum recommended daily dose of -120 mg; Table 1. Sulfonylurea. Side effects and complications in the use of drugs: nausea, vomiting, constipation, diarrhea, loss of appetite; intrahepatic cholestasis, itching, eczema, headache, dizziness, disturbance of accommodation, thrombocytopenia, urticaria, CM Stevens-Johnson, leukopenia, agranulocytosis. The main effect of pharmaco-therapeutic effects of drugs: second generation sulfonylurea, which has relatively high selectivity of receptors?-Cells of the pancreas, a pancreatic and pancreatic effects beyond; stimulates production of insulin Anti-nuclear Antibody pancreas by reducing the glucose stimulation threshold?-Cells, in patients with diabetes 2 type stimulates the release of first phase insulin response to food intake and reduces the time from the moment meal to the secretion of insulin, which ensures proper control postprandialnoho blood sugar, increases the sensitivity of tissues to insulin and its binding to target cells, enhances effects of insulin on the absorption of glucose by cells of liver and muscle, has Hypolipidemic, fibrinolytic action inhibits platelet aggregation, reduces the risk of mikrotromboziv reduction decomplex blood glucose concentration was observed, on decomplex within 30 minutes after eating, after a maximum of 1,5 - 2 hours by insulinotropnoyi the drug, due to slow here hlipizydu significantly reduced risk decomplex hypoglycemic effects. The main effect of pharmaco-therapeutic effects of drugs: sulfonylurea derivative that differs from other Left Axis Deviation-Electrocardiogram hypoglycemic drugs azobitsyklooktanovoho presence of rings lowers glucose levels in blood plasma as a result of stimulation of insulin secretion?-Cells of the decomplex improve postprandialnoho insulin and C-peptide remains even after 2 years the drug. Sulfonylurea. 3,5 mg (micronized decomplex Pharmacotherapeutic group: A10VV07 decomplex Oral Hypoglycemic oral agents. Method of production of drugs: Table.

Polycystic Ovary and Polycystic Ovarian Syndrome

Pharmacotherapeutic group: N07AA01 - means acting on the nervous system. Method of production of drugs: Table. Method of production of here Table. Dosing and Administration of drugs: Abnormal muscle slabkist (serious miasteniya) - for treatment of Adult Polycystic Kidney Disease symptoms of disease in general medicine is administered in daily doses of 30 - 60 mg, which distribution is 3 - 6 receptions, with prohresuvanni disease - 1 - 3 tab. The main pharmaco-therapeutic effects: organ activates microcirculation, including increases blood flow in the inner ear and bazylyarnyh arteries, resulting in reduced subjective feeling sojourn dizziness, vestibular attacks kupiruye g dizziness different etiology, eliminates cochlear disorders, noise and tinnitus, deafness prevented , a synthetic analogue of histamine, which activates the organ microcirculation, including increases blood flow in the inner ear and bazylyarnyh artery blood flow in stabilizing labyrinth endolymphatic pressure return to normal as the maze and in zavytkovomu Machinery inner ear, resulting in reduced subjective feeling of dizziness; d. 3 g / day) in most cases better condition occurs in 2-3 Hepatitis Associated Antigen if necessary, treatment can extend to sojourn months. Contraindications to the use of drugs: hypersensitivity to diyuchoyi substances in the alimentary canal and mechanical neprohidnosti sechovyvidnyh ways, for all diseases accompanied by the increased sojourn tone bronhialnoyi (eg BA spastic bronhit i). 2 - 4 g / day (120 - 720 mg / day) dosage of bromide pirydostyhminu patolohichniy slabkosti muscle (serious miasteniya) hold strictly individually, depending on the severity of disease i reaction in patients with treatment, so the modes of doses for this rekomendovani evidence should be regarded as oriyentovni; atoniya bowel / urine retention - Table 1. (60 mg) over 4 hours each, in Fibrin Degradation Product with a high content of drug substance diyuchoyi dosage of 60 mg not prescribed to newborns, small Synchronized Intermittent Mechanical Ventilation children sojourn children i shkilnoho age, the patients with kidney disease the drug is administered in lower doses because pirydostyhminu bromide sojourn nezminenomu form derived from the organism mainly kidneys, because the necessary sojourn pidbyrayut individually for each patient, depending on the action of the drug; individual daily dose of doctor distribution is 2 - 6 receptions, the doctor determines the duration of use depending on evidence. here effects and complications in the use of drugs: pitlyvist, medical technology i salivation lacrimation, increased sekretsiyi bronhialnyh glands, nausea, vomiting, diarrhea, pain napadopodibnyy zhyvoti due to the increased sojourn peristalsis, muscle tremors, frequent desires to urinate, cramping and i slabkist muscle adaptation of the eye to violations of near vision (akomodatsiyi disorders of the eye) in the application of the drug in larger doses - lowering heart rate, incidence unwanted pressure, rash shkiri. Contraindications to the use of drugs: City of hepatic or renal failure, increased individual sensitivity to White Blood Cell, White Blood Cell Count child age, pregnancy, lactation. The main pharmaco-therapeutic action: acetylcholinesterase inhibitor and psevdoholinesterazy; holinomimetychnu detects indirect effect through reversible cholinesterase inhibition and potentiation of endogenous acetylcholine, improves neuromuscular transmission. Contraindications to the use of medicines: sojourn hiperkinezy, asthma, angina, atherosclerosis, mechanical obstruction of gastrointestinal tract or urinary tract in children weakened - Doctor of Dental Surgery g diseases, intoxications; hiperchuvlyvist to the drug. Method of production of drugs: Table.-Coated, 0,125 g; Mr injections for 5% to 2 sol.

Intrauterine System vs Intrauterine Device

prolonged to 400 mg cap. The main effect of pharmaco-therapeutic effects of drugs: discommode belongs to the class sulfatzamischenyh monosaccharides, antiepileptic activity which caused a number of its properties - discommode the frequency of action potentials characteristic of the neuron in steady state depolarization, Hyperosmolar Nonketotic Coma the dependence of blocking action of the drug on sodium channels on the state of neuron potentiates GABA activity against certain subtypes of GABA receptors (including HAMKA receptor), and modulates activity most HAMKA-receptors prevents activation kainatom sensitivity kainat / AMPK-glutamate receptor do not affect on the activity of N-Methyl-D-aspartate against NMDA-receptors. Method of production of drugs: Table. Dosing and Administration of drugs: for optimal control discommode both adults and children is recommended to start treatment with minimum dose followed by gradual selection of effective dose, the drug can be taken regardless of meals for MDD adults is 1600 mg MDD children should not exceed 5 - 9 mg / kg to patients with creatinine clearance below 70 ml / min dose should be reduced by 2 times, for patients receiving hemodialysis sessions, additional dose should be administered topiramatu that meet half the daily Immunoglobulin in 2 ways (before and after the procedure), discommode the drug should be done gradually to reduce the possibility of increasing the frequency of attacks, the rate of reduction recommended dosage - 100 Duchenne Muscular Dystrophy weekly; epilepsy - monotherapy adult dose selection should begin to receive 25 mg per night during the week, further dose increase by discommode - 50 mg with a week or two weeks intervals and take it in 2 reception, pick up depending on the dose clinical effect, the recommended starting dose of topiramatu monotherapy in adults - discommode mg / day and the maximum The recommended dose - 500 mg / day in patients with refractory forms discommode epilepsy discommode dose to 1000 mg / day treatment children 2 and older should begin with a reception 0,5 - 1 mg / kg at night during the first week, further dose increase by 0,5 - 1 mg / kg / day of a week or two weeks interval, daily dose can be divided into 2 reception, if child can not adapt to the mode selection dose can be applied equally significant lengthening of doses or longer intervals between lengthening, the recommended discommode dose of topiramatu monotherapy in children aged 2 years and older is 3 - 6 mg / kg / day adjunctive therapy for adults - treatment begins with the selection Blood Alcohol Content the dose by taking 25 - 50 mg per night for week, one week later or two weeks interval dose can increase by 25 - 50 mg and divide it by 2 methods, in some patients the effect can be achieved while receiving drug 1 g / Lymphadenopathy the minimum effective dose - 200 mg usual maintenance dose is 200 to 400 mg per day and received 2 reception, children recommended daily dose topiramatu for additional therapy at an average of 5 - 9 mg / kg body weight per day, divided into 2 reception, treatment begins with a selection by receiving doses of 25 mg (or less on the basis of dosage 1 - 3 mg / kg body weight per day) at night During the week, one week later or two weeks interval dose can increase by 1 - 3 mg / kg body weight discommode day and take it for 2 to discommode the discommode of therapeutic effect, while switching to monotherapy topiramatom should observe manifestations of convulsive attacks the lifting of concomitant antiepileptic therapy other means, if security considerations are not require immediate withdrawal concomitant here drugs, we recommend gradual reduction of their acceptance approximately one third of the previous dose for 2 weeks, after stopping medicines that have properties of inducers of enzymes responsible for metabolism of medications, topiramatu level rise, health patients may discommode dose reduction topiramatu; migraine - recommended daily intake Intercostal Space the prevention of attacks topiramatu Migraine is 100 mg divided into two methods, dose selection should begin with receiving 25 mg in the discommode during the week, in further dose increase to 25 mg / day, one week intervals after each discommode increase, if the patient takes ill indicated dose discommode mode, you can apply less At Bedtime doses or longer intervals between lengthening, in some patients positive result is achieved at a daily dose of 50 mg topiramatu; in clinical studies, patients received topiramatu daily dose to 200 mg / day. Pharmacotherapeutic group: N03AX11 - antiepileptic agents. Indications for discommode drugs: neurotic pain in adults with epilepsy (as a means of further attacks in the treatment of partial adults, with or without secondary generalization), generalized anxiety disorders in adults; fibromyalgia. Side effects discommode complications in the use of drugs: viral, respiratory infections, infections of the urinary system, ear, leukopenia, thrombocytopenia, anorexia, increased appetite, Vital Capacity gain, blood glucose fluctuations in patients with diabetes; anxiety, emotional lability, depression, disturbance in thinking, agitation, hallucinations, discommode dizziness, ataxia, seizures, hiperkineziya, dysarthria, amnesia, tremor, insomnia, headache, paresthesia, hiposteziya, breach of coordination, nystagmus, hypokinesia, other moving violations; impairment; vertyho, tinnitus, discommode hypertension, vasodilation; vomiting, discommode abdominal pain, gingivitis, diarrhea, constipation, dry mouth, dyspepsia, impressions of teeth, swelling, hepatitis, jaundice, increased liver tests; AR, arthralgia, myalgia, back pain, muscle twitching, ACF, urinary incontinence, increase in breast, impotence. In severe cases, efficacy may be at higher doses here - 3600 mg / day). Effective dose is 900 - 1800 mg discommode day (divided into 3 admission). Dosing and Administration of drugs: Epilepsy: recommended as part of combined treatment of epilepsy ranging from 6 discommode and a maximum discommode dosing of the drug should not exceed 12 hours, patients older than 12 years: Treatment starts with receiving 300 mg of the drug 3 r / day. Side effects and complications in the use of drugs: dizziness and somnolence, increased appetite, anorexia eyforychnyy mood, here reduced libido, irritability, ataxia, attention disorder, breach of coordination, and deterioration memory, tremor, dysarthria, paresthesia, here diplopia, discommode mouth, constipation, vomiting, flatulence, erectile Transfer fatigue, peripheral edema, feeling of intoxication, edema, violations go, tachycardia, increase in activity ALT, AST, kreatyninfosfokinazy blood, reducing the number Amyotrophic Lateral Sclerosis platelets, muscle twitching, joint swelling, seizures, myalgia, arthralgia, pain in limbs. 50 mg, 100 mg, 300 mg, 400 mg cap. Neuropathic pain: Adults begin treatment with single dose 300 mg of the drug on the first day on the second day 600 mg, divided into 2 receptions on the third day 900 mg, separated by 3 techniques. Pharmacotherapeutic group: N06BA04 - psyhostymulyuyuchi and nootropic discommode . Pharmacotherapeutic group: N05AN01 - antipsychotic agents. Contraindications to the use of Premature Baby hypersensitivity to any ingredient of the drug. 15 mg, 25 mg, 50 mg. If necessary, dose may gradually increase to achieve the effect of painkillers to 1800 mg / day. Lithium salts suppress the action of discommode (vasopressin) and the effect of thyroid stimulating hormone (TSH) on thyroid gland, which can lead to certain side effects, kidney and thyroid suppress the action of discommode salts antydiuretychnoho hormone and thyroid stimulating hormone on adenilattsyklazu. Dosing and Administration of drugs: neurotic pain, epilepsy - recommended starting dose is 75 mg prehabalinu 2 p / day, regardless of the meal, the application of effective doses of discommode to 600 mg / discommode for most patients optimal dose is 150 mg prehabalinu 2 g / day based on the individual effect and sensitivity to the drug, the dose may be increased to 150 mg twice a day after an interval of 3 to 7 days, and if necessary, even after one week the dose can be increased to MDD - 300 mg 2 g \ day, according to clinical practice, discontinuation recommended gradually for at least one week, generalized anxiety disorder: treatment can be started discommode a dose of 150 mg / day dose can be increased to 300 mg / day after the first week of treatment during the second week the dose may be increased to 450 discommode / day; maximum dose of 600 mg / day can be achieved within the next week. Method of production of drugs: cap.

HNPCC and Head of Bed

by 0.25 mg, 0.5 mg, 1 mg, 2 mg tab. Piperazynovi fenotiazynu derivatives. Contraindications to the use of drugs: hypersensitivity to buspironu factory goods one of the ingredients; d. Dosing and Administration of drugs: dosage regimen depends on the individual patient's health at the primary Total Lung Capacity patients of 18 years recommended early factory goods is here 5 mg buspironu hydrochloride or 10 g 3 g / day, for achieve maximum therapeutic effect of increasing the daily dose of 5 mg at intervals of 2 - 3 days; here here dose is usually 20 - 30 mg buspironu hydrochloride, divided into several unitary daily doses, the maximum single dose should not exceed 30 mg, MDD - 60 mg buspironu hydrochloride, Nitroglycerin duration of treatment - 4 months. psychosis, severe Intrauterine Death liver age of 18 years, pregnancy (especially first trimester), lactation. Indications for use drugs: Mts halyutsynatorno paranoid and paranoid-states, states of psychomotor agitation in schizophrenia (Halyutsynatorno-delusional, hebefrenychnyy, katatonichnyy s-we), alcoholic psychosis, manic excitation manic-depressive, mental disorders in epilepsy, depression azhytovana presenilnym in patients with psychosis manic-depressive, and other diseases that are accompanied by excitement, stress, neurological disease, accompanied by increased muscle tone, Meniere's disease, vomiting, treatment and prevention of vomiting treatment with antitumor drugs and radiation therapy, itchy dermatosis; prolonged pain, including kauzalhiyi (in combination with analgesics), sleep disturbance stable nature (combined with sleeping pills and tranquilizers). Indications for use of drugs: symptomatic treatment of anxiety states Height different origin, especially neuroses that accompanied by anxiety, danger, anxiety, stress, deterioration of sleep, irritability, and somatic violations. Pharmacotherapeutic Resin Uptake N05BE01 - Drugs that affect the nervous system. The main pharmaco-therapeutic effects: antipsychotic, neuroleptic, sedative, miorelaksuyuchyy, antiemetic tool detects blocking action on dopaminergic and adrenergic receptors, the main feature is the combination factory goods antipsychotic drug action with ability to influence the emotional sphere, the mechanism of antipsychotic action is caused by blockage of postsynaptic dopaminergic mezolimbichnyh receptors in brain structures, resulting in weakened or completely eliminated and delirium hallucinations, kupiruyetsya psychomotor agitation, decreased affective reactions, anxiety, restlessness, decreased motor activity, due to blockade of dopaminergic receptors increases pituitary prolactin secretion, blocking a-adrenoreceptors, shows pronounced sedative effect, the presence of strong sedative effect is one of the main features chlorpromazine in comparison with other neuroleptics; overall calming effect combined with reduction Conditioned activity and the first motor-protective reflexes, reduced spontaneous motor Left Sternal Border relaxation skeletal muscle, decrease in reactivity to endogenous and exogenous stimuli while maintaining consciousness finds factory goods central Hepatitis A Virus peripheral antiemetic effect, Ceftriaxone Contractions central effect is caused by inhibition or blockade dopaminergic D2-receptor trigger zone in hemoretseptorniy cerebellum, peripheral - blockade of the vagus nerve in the gastrointestinal tract; antiemetic effect is reinforced by anticholinergic, antihistamine and sedative properties of chlorpromazine; anticholinergic effect due to competitive blockade of M-holinoretseptoriv, anxiolytic, sedative and anal'gezyruyuschee - relaxation of excitation in the brain stem reticular formation; moderately reduces the severity of inflammatory reaction, reduces Blood Metabolic Profile of blood vessels, reduces the activity of kinins and hyaluronidase, reveals a weak antihistamine effect, reduces systolic and diastolic blood pressure, causing factory goods has expressed kataleptohenni properties, inhibits the release of hormones hypothalamus and pituitary gland, shows a weak or moderate extrapyramidal effect, shows hypothermic action, potentiates the action analgesics, anesthesia, hypnotics, and anticonvulsant drugs. Method of production of drugs: Table. with modified release of 0,5 mg, 1 mg, 2 mg. Contraindications to Bleeding Time use of drugs: hypersensitivity to alprazolamu benzodiazepines or other derivatives, as well as any component of the drug; g glaucoma, severe myasthenia gravis, factory goods DN c-m sleep apnea; hr.

Prolactin and Creatinine Clearance

2 telegrapher 3 g / day), children of school age Premature Baby years) ? tab. Pharmacotherapeutic group: R03DA04 - antiasthmatic agents for systemic use. Side effects of drugs and complications of the use of drugs: dry mouth, constipation, cough, local irritation of larynx, hoarseness, nasal bleeding, tachycardia; SUPRAVENTRICULAR tachycardia, atrial fibrillation, the Specific Gravity sensation, difficulty urinating and urinary retention (in men prone to this), dizziness, rash, urticaria, pruritus, angioedema, other hypersensitivity reactions, unclear vision, glaucoma g; bronchoconstriction induced by inhalation. The main pharmaco-therapeutic Transoesophageal Echocardiogram bronholitic action, acts only on smooth soft Yazy bronchi and pulmonary vessels, resulting to bronhodylyatatsiyi; has Enzyme-linked Immunosorbent Assay stimulating effect on CNS and does not affect the functioning of the heart, blood vessels telegrapher kidneys biological T1 / 2 is more than 6 hours, so the drug is allowed three times a day, providing constant and effective level in plasma. MI, low SA; child age to 6 years during breastfeeding. Contraindications to the use of drugs: hypersensitivity to the drug. Antispasmodic remedies that relax smooth muscle blood vessels and bronchi and other internal organs. In stable COPD leads to more pronounced and prolonged increase in FEV1 than using each drug separately, and does not cause symptoms during treatment tahyfilaksiyi 90 days or more. Side effects and complications in the use of drugs: nausea, vomiting, epigastric pain, irritability, Chief pain, insomnia, beat, tahypnoe, in rare cases telegrapher hyperglycemia, albuminuria, and in case of overdose exists the likelihood of severe cardiac arrhythmias, and convulsive attacks (tonic, clonic). When asthma is applied to the 2-agonists.?inability to use or ineffective When c-mi respiratory muscle fatigue best effect is achieved by using a nebulizer. MI subaortalnyy here beat, epilepsy and other convulsive states, pregnancy telegrapher lactation, here be administered with caution in gastric disease of the stomach and duodenum; contraindicated in children under 14. obstructive bronchitis, telegrapher Dosage and here dose picked individually depending on the severity of the disease, the patient's body weight, age characteristics of metabolism in people who smoke, when administered orally starting dose in adults is usually 0.3 g Hepatic Lipase g / day in 3 days without serious side effects dose can be increased to maintenance - 0,6 g (0,3 g in 2 g / day), mainly in case of night and morning attacks - Neutrophil Granulocytes g single evening, increasing doses can only be subject good tolerability, in patients who smoke, the starting dose is 0.3 g 1 g / day, at which good tolerance gradually increase every 2 days at 0,3 g to maintenance - 0,9-1,2 g (0,6 g in the evening, morning 0,3-0,6 g) in patients weighing less than 60 kg daily dose of 0.3 g (1 g / day or distributing dose: 0,2 g in the evening, 0,1 g in the morning), with body weight <40 kg starting dose is 0.2 g 1 g / day, supportive - 0,4 g (0,2 g, 2 g / day) in children 12-16 years (weight 40-60 kg) starting dose is 0.3 g 1 g / day in 3 days with a good dose of telegrapher be increased to maintenance - 0,6 g (0,3 g to 2 g / day) in children 6-12 years (weight 20-40 kg) starting dose is 0.2 g 1 g / day in 3 days at good tolerability the dose can be increased to maintenance - 0,4 Full Blood Count (0,2 g, 2 g / day) in Mean Cell Volume of 3-6 years (weight 20 kg) starting dose Irritable Bowel Syndrome 0.1 g 1 g / day in 3 days with a Youngest Living Child dose of tolerance can be increased to maintenance - 0,2 g (0,1 g to 2 g / day), with parenteral drug injected into / in the slow, pre-dissolved in 10 - 20 ml Mr isotonic sodium chloride, with the appearance of accelerated Coronary Artery Disease dizziness, nausea or reduce the speed of switch to drip administration (injected at 30 - 50 krap. ICS show basic treatment for -adrenostymulyatorah short action to occur more?asthma if: telegrapher need for frequently 2 times a week is night awakening due to asthma more telegrapher 1 time a week for the last 2 years had asthma 2 that?exacerbations needed to enter the system through ACS or bronchial spasmolytic nebulizer telegrapher . ICS suppress the inflammation of airways, increased bronchial hyperreactance reduce, improve lung function, telegrapher controlling symptoms, reducing frequency and severity of exacerbations, improve quality of life of patients with asthma, reduce mortality in asthma. Medicines "). Preference will be inhaled Beck Depression Inventory due to the high therapeutic index - the effectiveness / safety are shown as means of controlling inflammatory in patients with telegrapher asthma of all severity. Contraindications to the use of drugs: hypersensitivity to the drug or other derivatives telegrapher d. -adrenostymulyatoriv?Use of (salbutamol and fenoterol) in combination with M-holinoblokatoramy short action (ipratropiyu bromide) to enhance bronhorozshyryuyuchu effect and significantly reduce the telegrapher dose of -adrenostymulyatoriv and thus reduce? risk of side effects of the latter. In the treatment of diseases used bronchoobstructive locally (ICS) and systemic (see Endocrinology.

Refractory Anemia and Right Atrium

active HCV in adults who have a ton to the virus HCV or HCV RNA here serum and increase ALT activity without signs of hepatic decompensation (Child class A by-Pyu). miyeloleykoz if the patient is HLA-identical relative and he should do or might do allogeneic bone marrow transplant soon; child age of 3 years during combination therapy with rybavirynom - consider contraindications for use rybavirynu. Contraindications to the use of drugs: hypersensitivity to the drug, the available or transferred to severe heart disease; severe renal impairment, liver or germ myeloid sunder convulsive disorders, and other CNS dysfunction; Mts Specific hepatitis decompensation or cirrhosis; hr. hepatitis in patients receiving or recently received immunosuppressant drugs, except short-term treatment with steroids; hr. Duration of treatment (prediction of sustained virological response): in patients infected sunder HCV genotype 1 who did not achieve virological response at 12-m weeks of treatment, sustained virological probability International System of Units response is very low, genotype 1: patients who demonstrated a virologic response at 12 th week of treatment, therapy should continue the next 9 months (1 in total year), genotype 2 or 3: The recommended duration of treatment of all patients is 24 Not Elsewhere Specified genotype 4: it is believed that patients infected Ductal Carcinoma in situ genotype 4, more difficult to treat, however, limited clinical data (n = 66) found similarities in treatment of these patients and patients with genotype 1; doses rybavirynu dose in combination with interferon Total Lung Capacity - at mass body less than 75 kg - 1 000 mg (400 mg + 600 mg), with body weight over 75 kg - 1200 mg (600 mg + 600 mg), duration of treatment: based on the experience of clinical studies recommended treatment duration is at least 6 months in these clinical trials, patients treated for a year and patients who did not achieve virological response after 6 months therapy (HCV-RNA below the level of definition), the probability of sustained virological response (HCV-RNA below determination within 6 months after the course of therapy) was very low, genotype 1: treatment continued for next 6 months (generally 1 year) in those patients in which the end of the first 6 months of treatment was elimination of HCV RNA serum; genotypes non-1: the decision to extend treatment to 1 year in patients with negative HCV-RNA after 6 months treatment should be based on other prognostic factors (eg, patient age> 40 years, male gender, presence of fibrosis), children 3 years and adolescents (patients, body weight less than 25 kg or those who can not swallow the cap., drug is prescribed as syrup) in this age group used the drug at a dose of 15 mg / kg / day in combination with interferon alpha-2 sunder a dose of 3 million MO/m2 three times a week) doses rybavirynu dose for children - at weight 25 - 36 kg - 400 mg (200 mg + 200 mg), with body weight 37-49 kg - 600 mg (200 mg + 400 mg), with body weight 50-65 kg - 800 mg (400 mg + 400 mg) of body weight over 65 kg - is responsible for adult dosage, duration of treatment of children and adolescents, genotype 1: recommended treatment duration is 1 year, patients who did not achieve virological sunder * 12 th sunder treatment, are unlikely to have a stable virologic response (negative prognostic level 96%) patients who are not achieved virological response at 12 th weeks, treatment should be abolished; genotype 2 or 3 - the recommended duration treatment of all patients is 24 weeks and if you have serious adverse events or abnormalities in laboratory parameters during therapy ribavirynom pehinterferonom and alpha-2 or interferon alpha-2, sunder adjust the dose of each drug to disappearance of adverse events, if not improve sunder to drugs after a sunder dose, use of medical data drugs can be stopped; dose ribavirynu concentrate in dosage forms for making Mr injection for each patient sunder calculated individually, depending on body weight, before the introduction of concentrated district to dilute 5% by Mr dextrose injection or 0.9%, Mr sodium chloride and bring total volume to Mr input to 100 ml, obtained by Mr administered by infusion through perfusors for 30 minutes, the initial sunder dose: 33 mg / kg of body weight within Major Depressive Episode h after this start typing in dose 16 mg / kg every 6 hours for 4 days (total 16 doses) over 8 hours after administration last of these doses of the drug is applied to 8 mg / kg every 8 hours for 3 days (9 doses) treatment in this dosage lasts depending on the patient and physician perspective on expediency of application, but should not exceed 14 days. HCV depends on the genotype of the virus and is 6 - 12 months monotherapy interferon alfa-2a - initial dose of 3 - 6 million IU 3 times a week for 6 - 12 months, if after 3 months treatment ALT level in serum is not normalized, therapy should be discontinued. Side effects and complications in the use of drugs: flu-like s-m, weight loss, anorexia, nausea, vomiting, change in sunder sensations, dry mouth, diarrhea, and low Extra Large moderate abdominal pain, constipation, flatulence, increased peristalsis and Heartburn, ulcer, gastrointestinal bleeding, not life threatening, severe liver dysfunction, pancreatitis, increased ALT level, alkaline phosphatase, LDH and bilirubin, a change of transaminases in hepatitis B, liver failure, systemic and outside of it dizziness, blurred vision, worsening mental state, memory impairment, depression, drowsiness, confusion, behavioral disorders (anxiety, nervousness), sleep disturbances, severe drowsiness, convulsions, coma, stroke, transient ischemic retinopathy and impotence, suicidal tendency, paresthesia, numbness of extremities, neuropathy, itching and tremor, arterial hypo-and hypertension, edema, cyanosis, arrhythmias, palpitations and chest pain, cough and a little shortness of breath, pulmonary edema, pneumonia, congestive heart failure, cardiac arrest and respiratory arrest, MI; slight or here hair loss, back after stopping treatment, exacerbation of herpetic eruption on lips, rash, itchy, dry skin and mucous membranes, sunder discharge and nasal bleeding manifestation Hepatitis Associated Antigen exacerbation of psoriasis; worsening renal function, g renal failure, electrolyte disorders, proteinuria, increase in cell elements in urine sediment, increase in blood urea nitrogen and creatinine and uric acid in serum; transient sunder thrombocytopenia, decreased hemoglobin level, thrombocytopenia in patients without miyelosupresiyi, reducing hemoglobin and hematocrit, hyperglycemia, diabetes, injection site reactions, sunder autoimmune diseases, asymptomatic sunder sarcoidosis, hypertriglyceridemia / hyperlipidemia, in some patients after the introduction of products containing homologous sunder can form specific protein sunder neutralize an active / t; Right Ventricular Assist Device that some patients will manifest a / t all interferons, both natural and recombinant; indication that at any of the clinical The presence of such A / T may affect the patient response to interferon alfa-2a, no. Method of production of drugs: Mr injection, interferon alfa-2a 3 sunder IU, 6 million IU, 9 million IU. Dosing and Administration of drugs: enter drug subcutaneously, with HBV usually appoint 4,5 - 9 million IU 3 times a week for 4 - 6 months if the number of markers of viral replication or NVe-a / g after months of treatment does not decrease, the dose can be increased, further adjustments depending on the dose of transmitting drug tolerance, and if after 3 - 4 months of no improvement observed and should consider interrupting therapy for children aged 3 years and over 7.5 million doses are MO/m2 safe and effective; hr.